BioSpace News Archive

Drug Development

Caladrius Receives FDA Regenerative Medicine Advanced Therapy Designation for CD34+ Cell Therapy for Treating Refractory Angina

Caladrius Biosciences, Inc. announces today that that the U.S. Food and Drug Administration has granted RMAT designation to the Company’s late-stage CD34+ cell therapy program.

June 19, 2018
·
5 min read
Business

Stimwave Appoints Industry Veteran Steven Amelio as Chief Financial Officer

Stimwave LLC announced the appointment of industry veteran Steven Amelio to the position of Chief Financial Officer (CFO).

June 19, 2018
·
3 min read
Business

Creative Medical Technology Holdings Forms CaverStem International LLC

Subsidiary to concentrate on International Erectile Dysfunction Market

June 19, 2018
·
3 min read
Business

Home Care Solutions is Now SmithLife™ Homecare

Home Care Solutions is pleased to announce a new name and logo.

June 19, 2018
·
1 min read
BioCapital

Apex Systems and Apex Life Sciences Win Industry Award for Staffing Innovation: Most Innovative Use of Technology – Large Firms

Apex Systems and Apex Life Sciences, a leading scientific, engineering, and clinical research services company, are proud to announce they were selected as winners of the 2018 Bullseye Award for Staffing Innovation: Most Innovative Use of Technology – Large Firms.

June 19, 2018
·
3 min read
Drug Development

ITM: FDA Acceptance of IND to Advance Phase III Clinical Trial COMPETE with Solucin® for Treatment of GEP-NET in the U.S.

Isotopen Technologien München AG announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Investigational New Drug Application (IND) to advance its innovative radiopharmaceutical Solucin® (n.c.a. 177Lu-Edotreotide), into a phase III clinical trial in the U.S..

June 19, 2018
·
3 min read
Policy

Statement from Douglas Throckmorton, M.D., deputy center director for regulatory programs in FDA’s Center for Drug Evaluation and Research, on the agency’s response to ongoing drug shortages for critical products

Statement from Douglas Throckmorton, M.D., deputy center director for regulatory programs in FDA’s Center for Drug Evaluation and Research

June 19, 2018
·
8 min read
Policy

Former White House Special Counsel Lanny Davis to Hold Telephonic Press Conference on Behalf of Dr. Carlos Beharie Challenging Hospital for Hostile Actions That Caused the Destruction of Dr. Beharie’s OB/GYN Practice in Southern California

Audio Press Conference 11:00 am PDT Wednesday

June 19, 2018
·
1 min read
Deals

Kindred Biosciences Announces Proposed Public Offering of Common Stock

Kindred Biosciences, Inc. announced a proposed public offering of its common stock.

June 19, 2018
·
5 min read
Deals

Achieve Life Sciences, Inc. Announces Closing of a $13.8 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

Achieve Life Sciences, Inc. announced the closing of an underwritten public offering of units for gross proceeds of $13.8 million

June 19, 2018
·
3 min read